loadpatents
name:-0.025938987731934
name:-0.020197153091431
name:-0.00061607360839844
Schoentjes; Bruno Patent Filings

Schoentjes; Bruno

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schoentjes; Bruno.The latest application filed is for "inhibitors of the interaction between mdm2 and p53".

Company Profile
1.30.30
  • Schoentjes; Bruno - Bois-Guillaume FR
  • Schoentjes; Bruno - Ville d'Avray FR
  • Schoentjes; Bruno - Bois-Gullaume FR
  • Schoentjes; Bruno - Sevres FR
  • Schoentjes; Bruno - Brussels BE
  • SCHOENTJES; Bruno - Brussel BE
  • Schoentjes; Bruno - Val de Reuil FR
  • Schoentjes; Bruno - Rouen FR
  • Schoentjes; Bruno - Strasbourg FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitors Of The Interaction Between MDM2 And P53
App 20200121667 - Poncelet; Virginie Sophie ;   et al.
2020-04-23
Inhibitors Of The Interaction Between MDM2 And P53
App 20180263966 - Poncelet; Virginie Sophie ;   et al.
2018-09-20
Composition comprising a complex of (+)-catechin and amino acid for the treatment and prevention of cancer
Grant 9,844,595 - Niebes , et al. December 19, 2
2017-12-19
Inhibitors Of The Interaction Between Mdm2 And P53
App 20170112818 - Poncelet; Virginie Sophie ;   et al.
2017-04-27
Inhibitors of the interaction between MDM2 and P53
Grant 9,573,933 - Poncelet , et al. February 21, 2
2017-02-21
Macrocylic Pyrimidine Derivatives
App 20170022202 - DIELS; Gaston Stanislas Marcella ;   et al.
2017-01-26
Macrocylic Pyridine Derivatives
App 20170022201 - Diels; Gaston Stanislas Marcella ;   et al.
2017-01-26
Oral Composition Comprisng (+)-catechin
App 20160095923 - Niebes; Paul ;   et al.
2016-04-07
Composition Comprising A Complex Of (+)-catechin And Amino Acid For The Treatment And Prevention Of Cancer
App 20160089358 - Niebes; Paul ;   et al.
2016-03-31
Benzocycloheptane and benzoxepine derivatives
Grant 9,040,725 - Schoentjes , et al. May 26, 2
2015-05-26
Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53
Grant 8,853,406 - Poncelet , et al. October 7, 2
2014-10-07
Benzocycloheptane And Benzoxepine Derivatives
App 20140187557 - Schoentjes; Bruno ;   et al.
2014-07-03
Benzocycloheptane and benzoxepine derivatives
Grant 8,703,973 - Schoentjes , et al. April 22, 2
2014-04-22
Diaza-spiro-{4,4}-nonane derivatives as neurokinin (NK.sub.1) antagonists
Grant 8,604,200 - Janssens , et al. December 10, 2
2013-12-10
Indole derivatives as anticancer agents
Grant 8,541,442 - Schoentjes , et al. September 24, 2
2013-09-24
Inhibitors of the interaction between MDM2 and P53
Grant 8,404,683 - Lacrampe , et al. March 26, 2
2013-03-26
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53
Grant 8,377,961 - Lacrampe , et al. February 19, 2
2013-02-19
Inhibitors Of The Interaction Between Mdm2 And P53
App 20130005769 - Storck; Pierre Henri ;   et al.
2013-01-03
Benzocycloheptane And Benzoxepine Derivatives
App 20120322796 - SCHOENTJES; Bruno ;   et al.
2012-12-20
Inhibitors of the interaction between MDM2 and p53
Grant 8,288,377 - Storck , et al. October 16, 2
2012-10-16
Benzocycloheptane and benzoxepine derivatives
Grant 8,278,466 - Schoentjes , et al. October 2, 2
2012-10-02
Inhibitors of the interaction between MDM2 and P53
Grant 8,232,298 - Lacrampe , et al. July 31, 2
2012-07-31
Cyclic-alkylamine Derivatives As Inhibitors Of The Interaction Between Mdm2 And P53
App 20120071508 - Lacrampe; Jean Fernand Armand ;   et al.
2012-03-22
Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
Grant 8,138,334 - Jenssens , et al. March 20, 2
2012-03-20
Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53
Grant 8,088,795 - Lacrampe , et al. January 3, 2
2012-01-03
Indole Derivatives As Anticancer Agents
App 20110294846 - Schoentjes; Bruno ;   et al.
2011-12-01
Substituted Phenylenediamines As Inhibitors Of The Interaction Between Mdm2 And P53
App 20110130418 - Poncelet; Alain Philippe ;   et al.
2011-06-02
Inhibitors of the Interaction Between MDM2 and P53
App 20110053937 - Lacrampe; Jean Fernand Armand ;   et al.
2011-03-03
Benzocycloheptane And Benzoxepine Derivatives
App 20110046139 - Schoentjes; Bruno ;   et al.
2011-02-24
Therapeutic use of acylaminothiazole derivatives
Grant 7,879,889 - Despey-Roux , et al. February 1, 2
2011-02-01
Substituted Oxa-diaza-spiro-[5.5]-undecanone Derivatives And Their Use As Neurokinin Antagonists
App 20100292228 - Jenssens; Frans Eduard ;   et al.
2010-11-18
Inhibitors of the interaction between MDM2 and p53
Grant 7,834,016 - Lacrampe , et al. November 16, 2
2010-11-16
Inhibitors of the Interaction Between MDM2 and P53
App 20100240637 - Poncelet; Virginie Sophie ;   et al.
2010-09-23
Use of acylaminothiazole derivatives as therapeutic agents
Grant 7,795,289 - Baltzer , et al. September 14, 2
2010-09-14
Inhibitors of the Interaction Between MDM2 and P53
App 20100216770 - Storck; Pierre-Henri ;   et al.
2010-08-26
Cyclic-alkylamine Derivatives As Inhibitors Of The Interaction Between Mdm2 And P53
App 20100168163 - Lacrampe; Jean Fernand Armand ;   et al.
2010-07-01
Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists
Grant 7,612,056 - Janssens , et al. November 3, 2
2009-11-03
Therapeutic Use of Acylaminothiazole Derivatives
App 20090253753 - DESPEYROUX; Pierre ;   et al.
2009-10-08
Diaza-spiro--nonane derivatives as neurokinin (nk1) antagonists
App 20090221641 - Janssens; Frans Eduard ;   et al.
2009-09-03
Acylaminothiazole derivatives, their preparation and their therapeutic use
Grant 7,563,903 - Despeyroux , et al. July 21, 2
2009-07-21
Inhibitors Of The Interaction Between Mdm2 And P53
App 20090149493 - Lacrampe; Jean Fernand Armand ;   et al.
2009-06-11
Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
Grant 7,544,694 - Janssens , et al. June 9, 2
2009-06-09
Use of Acylaminothiazole Derivatives as Therapeutic Agents
App 20080051436 - BALTZER; Sylvie ;   et al.
2008-02-28
Inhibitors of the Interaction Between Mdm2 and P53
App 20080039472 - Lacrampe; Jean Fernand Armand ;   et al.
2008-02-14
Acylaminothiazole derivatives, preparation and therapeutic use thereof
Grant 7,291,636 - Baltzer , et al. November 6, 2
2007-11-06
Substituted Diaza-Spiro-[4.5]-Decane Derivatives and Their Use as Neurokinin Antagonists
App 20070254904 - Janssens; Frans Eduard ;   et al.
2007-11-01
Substituted Diaza-Spiro-[5.5]-Undecane Derivaties and Their Use as Neurokinin Antagonists
App 20070232636 - Janssens; Frans Eduard ;   et al.
2007-10-04
Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
Grant 7,119,086 - Di Malta , et al. October 10, 2
2006-10-10
Acylaminothiazole derivatives, their preparation and their therapeutic use
App 20060052426 - Despeyroux; Pierre ;   et al.
2006-03-09
Acylaminothiazole derivatives, preparation and therapeutic use thereof
App 20050182104 - Balter, Sylvie ;   et al.
2005-08-18
Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
App 20040180878 - Di Malta, Alain ;   et al.
2004-09-16
1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
Grant 6,624,164 - Schoentjes , et al. September 23, 2
2003-09-23
Novel 1,3-dihydro-2h-indol-2-one Derivatives, Preparation Method And Pharmaceutical Composition Containing Them
App 20030139413 - Schoentjes, Bruno ;   et al.
2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed